Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Colorectal Neoplasms 2Thyroid Neoplasms 1Solid Tumors 1Sarcopenia 1Motor Activity 1Lung Neoplasms 1Liver Neoplasms 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Sorafenib 61Bevacizumab 42Oxaliplatin 24Doxorubicin 22Radiosurgery 20Gemcitabine 20Fluorouracil 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17Capecitabine 17lenvatinib 16Cisplatin 16atezolizumab 13Leucovorin 13Radiotherapy 11tremelimumab 10Cyclophosphamide 10Carboplatin 10Irinotecan 9Ipilimumab 9Drug Therapy 9Everolimus 8Cryosurgery 8toripalimab 7fludarabine 7Sunitinib 7Chemotherapy, Adjuvant 7Melphalan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liver Neoplasms × Whey Proteins × Clear all
NCT01542281 2012-03-02

Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Unknown
64 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡